Why the study?
Cardiac surgery-associated acute kidney injury is a common complication with complex etiology and no effective pharmacologic therapies, requiring clinicians to minimize renal dysfunction risk.
This narrative review summarizes current evidence on risk prediction, preoperative optimization, and perioperative management to minimize the risk of cardiac surgery-associated acute kidney injury.
Observational data associate transfusion volume with CSA-AKI; leaves open whether targeted reduction strategies improve renal outcomes.
Acute kidney injury (AKI) is one of the most common major complications of cardiac surgery, and is associated with increased morbidity and mortality. Cardiac surgery-associated AKI has a complex, multifactorial etiology, including numerous factors such as primary cardiac dysfunction, hemodynamic derangements of cardiac surgery and cardiopulmonary bypass, and the possibility of a large volume of blood transfusion. There are no truly effective pharmacologic therapies for the management of AKI, and, therefore, anesthesiologists, intensivists, and cardiac surgeons must remain vigilant and attempt to minimize the risk of developing renal dysfunction. This narrative review describes the current state of the scientific literature concerning the specific aspects of cardiac surgery-associated AKI, and presents it in a chronological fashion to aid the perioperative clinician in their approach to this high-risk patient group. The evidence was considered for risk prediction models, preoperative optimization, and the intraoperative and postoperative management of cardiac surgery patients to improve renal outcomes.
No takes yet. Share an insight, caveat, or question.
Milne et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: